Effects of subinhibitory concentrations of florfenicol on morphology, growth, and viability of Staphylococcus aureus

Journal of Veterinary Medicine Series B: Infectious Diseases and Veterinary Public Health

Volumn 51, Issue 6, 2004, Pages 293-296

  Blickwede, M ^a   Valentin Weigand, P ^a,b   Rohde, M ^a,c   Schwarz, S ^a  

^a INSTITUT FÜR TIERZUCHT   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DRUG DERIVATIVE; FLORFENICOL; THIAMPHENICOL;

ANIMAL; ANIMAL DISEASE; ARTICLE; CATTLE; CATTLE DISEASE; CLASSIFICATION; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PHYSIOLOGY; RESPIRATORY TRACT INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SWINE; SWINE DISEASE; ULTRASTRUCTURE;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CATTLE DISEASES; MICROBIAL SENSITIVITY TESTS; RESPIRATORY TRACT INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SWINE; SWINE DISEASES; THIAMPHENICOL;

STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 6344294137     PISSN: 09311793     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0450.2004.00767.x     Document Type: Article

References (31)

1. Blickwede, M., and S. Schwarz, 2004: Molecular analysis of florfenicol-resistant Escherichia coli isolates from pigs. J. Antimicrob. Chemother. 53, 58-64.
2. Cloeckaert, A., S. Baucheron, G. Flaujac, S. Schwarz, C. Kehrenberg, J. L. Martel, and E. Chaslus-Dancla, 2000: Plasmid-mediated florfenicol resistance by the floR gene in Escherichia coli isolated from cattle. Antimicrob. Agents. Chemother. 44, 2858-2860.
3. Cole, R. M., A. N. Chatterjee, R. W. Gilpin, and F. E. Young, 1974: Ultrastructure of teichoic acid-deficient and other mutants of staphylococci. Ann. N. Y. Acad. Sci. 236, 22-52.
4. De Haas, V., M. Bonnier, M. Gicquel, F. Etore, and D. Shuster, 2002: Florfenicol: a time- or concentration-dependent antibiotic? New Advances in Calf Disease Management, pp. 17-25. XXII World Buiatrics Congress, Hannover, Germany.
5. Docic, M., and G. Bilkei, 2003: Differences in antibiotic resistance in Escherichia coli, isolated from East-European swine herds with or without prophylactic use of antibiotics. J. Vet. Med. B. 50, 27-30.
6. Doublet, B., S. Schwarz, E. Nußbeck, S. Baucheron, J. L. Martel, E. Chaslus-Dancla, and A. Cloeckaert, 2002: Molecular analysis of chromosomally florfenicol resistant Escherichia coli isolates from France and Germany. J. Antimicrob. Chemother. 49, 49-54.
7. Eliopoulos, B. M., and R. C. Moellering, 1996: In: Lorian, V. (ed.), Antibiotics in Laboratory Medicine, 4th edn, pp. 104-105. William & Wilkins Co., Baltimore, MD, U.S.A.
8. Giesbrecht, P., and H. Ruska, 1968: Über Veränderungen der Feinstruktur von Bakterien unter der Einwirkung von Chloramphenicol. Klin. Wochenschr. 46, 575-582.
9. Giesbrecht, P., T. Kersten, H. Maidhof, and J. Wecke, 1998: Staphylococcal cell wall: morphogenesis and fatal variations in the presence of penicillin. Microbiol. Mol. Biol. Rev. 62, 1371-1414.
10. Graham, R., D. Palmer, B. C. Pratt, and C. A. Hart, 1988: In vitro activity of florphenicol. Eur. J. Clin. Microbiol. Infect. Dis. 7, 691-694.
11. Hancock, R., and J. T. Park, 1958: Cell-wall synthesis by Staphylococcus aureus in the presence of chloramphenicol. Nature. 181, 1050-1052.
12. Hirose, K., H. Kobayashi, N. Ito, Y. Kawasaki, M. Zako, K. Kotani, H. Ogawa, and H. Sato, 2003: Isolation of mycoplasmas from nasal swabs of calves affected with respiratory diseases and antimicrobial susceptibility of their isolates. J. Vet. Med. B 50, 347-351.
13. Hörmansdorfer, S., and J. Bauer, 1996: Zur Resistenzsituation boviner Pasteurellen [Resistance pattern of bovine pasteurellae]. Berl. Münch. Tierärztl. Wschr. 109, 168-171.
14. Hörmansdorfer, S., and J. Bauer, 1998: Zur Resistenz boviner und porciner Pasteurellen gegenüber Florfenicol und anderen Antibiotika [Resistance of bovine and porcine pasteurellae against florfenicol and other antibiotics]. Berl. Münch, Tierärztl. Wschr. 111, 422-426.
15. Johannsen, L., H. Labischinski, B. Reinecke, and P. Giesbrecht, 1983: Changes in the chemical structure of walls of Staphylococcus aureus grown in the presence of chloramphenicol. FEMS MicrobioL Lett. 16, 313-316.
16. Kehrenberg, C. and S. Schwarz, 2004: fexA, a novel Staphylococcus lentus gene encoding resistance to florfenicol and chloramphenicol. Antimicrob. Agents Chemother. 48, 615-618.
17. Kehrenberg, C., J. Mumme, J. Wallmann, J. Verspohl, R. Tegeler, T. Kühn, and S. Schwarz, 2004: Monitoring of florfenicol susceptibility among bovine and porcine respiratory tract pathogens collected in Germany during the years 2002 and 2003. J. Antimicrob. Chemother. 54, 572-574.
18. Mandelstam, J., and H. J. Rogers, 1958: Chloramphenicol-resistant incorporation of amino acids into staphylococci and cell wall synthesis. Nature 181, 956-957.
19. Mandelstam, J., and H. J. Rogers, 1959: The incorporation of amino acids into the cell-wall mucopeptide of staphylococci and the effect of antibiotics on the process. Biochem. J. 72, 654-662.
20. National Committee for Clinical Laboratory Standards (NCCLS), 2002: Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals, Approved standard - 2nd edn. NCCLS document M31-A2. NCCLS, 940 West Valley Road, Suite 1400, Wayne, PA 19087, USA.
21. Noviello, S., F. Ianniello, S. Leone, and S. Esposito, 2003: Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens. J. Antimicrob. Chemother. 52, 869-872.
22. Priebe, S., and S. Schwarz, 2003: In vitro activities of florfenicol against bovine and porcine respiratory tract pathogens. Antimicrob. Agents. Chemother. 47, 2703-2705.
23. Schlegelova, J., V. Babak, E. Klimova, J. Lukasova, P. Navratilova, A. Sustackova, I. Sediva, and D. Rysanek, 2002: Prevalence and resistance to antimicrobial drugs in selected microbial species isolated from bulk milk samples. J. Vet. Med. B. 49, 216-225.
24. Schwarz, S., 1994: Increased cell wall thickness and its effects on potential virulence properties of tetracycline-resistant Staphylococcus aureus. Med. Microbiol. Lett. 3, 16-22.
25. Schwarz, S., and E. Chaslus-Dancla, 2001: Use of antimicrobials in veterinary medicine and mechanisms of resistance. Vet. Res. 32, 201-225.
26. Schwarz, S., C. Werckenthin, and C. Kehrenberg, 2000: Identification of a plasmid-borne chloramphenicol/florfenicol resistance gene in Staphylococcus sciuri. Antimicrob. Agents Chemother. 44, 2530-2533.
27. Schwarz, S., C. Kehrenberg, B. Doublet, and A. Cloeckaert, 2004: Molecular basis of bacterial resistance to chloramphenicol and florfenicol. FEMS Microbiol. Rev. in press.
28. Seepersadsingh, N., and A. A. Adesiyun, 2003: Prevalence and antimicrobial resistance of Salmonella spp. In pet mammals, reptiles, fish aquarium water, and birds in Trinidad. J. Vet. Med. B 50, 488-493.
29. Wecke, J., M. Lahav, P. Blümel, and P. Giesbrecht, 1989: Reduced wall degradation of staphylococci after pretreatment with bacteriostatic antibiotics. In: Gillissen G., W. Opferkuch, G. Peters, and G. Pulverer (eds), The Influence of Antibiotics on the Host-Parasite Relationship, pp. 63-68. Springer Verlag KG, Berlin, Germany.
30. Wecke, J., L. Johannsen, and P. Giesbrecht, 1990: Reduction of wall degradability of clindamycion-treated staphylococci within macrophages. Infect. Immun. 58, 197-204.
31. Werckenthin, C., S. Seidl, J. Riedl, E. Kiossis, G. Wolf, R. Stolla, and O.-R. Kaaden, 2002: Escherichia coli isolates from young calves in Bavaria: in vitro susceptibilities to 14 anti-microbial agents. J. Vet. Med. B 49, 61-65.